As of November 6, 2026, Exagen Inc. is a publicly traded company (Nasdaq: XGN); its largest reported holder is NMSIC Co-Investment Fund, L.P., with 6.04% on Schedule 13G/A of February 11, 2026, then Parian Ultreia LP (5.3%). The largest insider holding is Jorey Chernett, a 10% owner, with 2,618,540 shares (10.8% of shares outstanding), per Form 4 of October 20, 2026 (Schedule 13G/A, February 11, 2026).
Is this your company?
About to sign with, pay or invest in Exagen Inc.? See the free Snapshot first.
Free to see. No signup.
Is Exagen Inc. a real, registered company?
- Exagen Inc. files with the SEC under CIK 1274737 (its SEC filings).
- Its shares are listed under the ticker XGN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Vista, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under EXAGEN INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Ana Hooker, Director (Form 8-K filed 2026-04-23). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Parian Ultreia LP (filed 2026-05-27).
Who are Exagen Inc.'s owners and officers?
Exagen Inc.: incorporated in Delaware; business address in Vista, California; industry Services-Medical Laboratories (Schedule 13G, 2026-05-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-05-27 | Parian Ultreia LP | 5.3% |
| Schedule 13G/A, 2026-05-20 | Chernett Jorey | 9.9% |
| Schedule 13G/A, 2026-02-17 | Rtw Investments, LP | 4.9% |
| Schedule 13G/A, 2026-02-11 | Nmsic Co-Investment Fund, L.P. | 6.04% |
| Schedule 13G, 2026-02-04 | Chernett Jorey | 5.4% |
| Schedule 13G/A, 2025-08-14 | Rtw Investments, LP | 7.7% |
| Schedule 13G/A, 2025-08-14 | Lytton Laurence W | 1% |
Questions about who owns Exagen Inc.
Who owns Exagen Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Exagen Inc.: Chernett Jorey (9.9%, Schedule 13G/A, filed 2026-05-20), Nmsic Co-Investment Fund, L.P. (6.04%, Schedule 13G/A, filed 2026-02-11) and Parian Ultreia LP (5.3%, Schedule 13G, filed 2026-05-27).
Who are the largest shareholders of Exagen Inc.?
By the share each holder's latest filing reports, the largest holders of Exagen Inc. on this page are Chernett Jorey (9.9%), Nmsic Co-Investment Fund, L.P. (6.04%) and Parian Ultreia LP (5.3%).
When did Chernett Jorey buy into Exagen Inc.?
The filings give report dates, not purchase dates. The earliest filing from Chernett Jorey on this page is the Schedule 13G, filed 2026-02-04, reporting 5.4%; its latest, Schedule 13G/A filed 2026-05-20, reports 9.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Exagen Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Exagen Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Exagen Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-23 | Ana Hooker | Director | departed | 2026-04-17 |
Which insiders own Exagen Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 2,618,540 shares (10.8% of shares outstanding) (Form 4, 2026-10-20).
- Sun Mountain Capital Partners LLC, a 10% owner: 1,758,958 shares (7.3% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-03-27).
- NMSIC Co-Investment Fund, L.P., a 10% owner: 1,758,958 shares (7.3% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2025-03-27).
- , the chief executive and president: 845,941 shares (3.5% of shares outstanding), 805,540 held directly and 40,401 indirectly (Form 4, 2026-10-19).
- , the chief financial officer: 324,910 shares (1.3% of shares outstanding) (Form 4, 2026-09-02).
Shares outstanding: 24,225,339 as of 2026-07-30, from the company's latest SEC cover page.
How much has Exagen Inc. raised?
No fundraising or offering filing from Exagen Inc. is on file with us.
Keep reading
More on Exagen Inc. and the records around it.
Exagen Inc. elsewhere on the record
- 5%+ stake filings May 2026
Companies that share a holder
- Parian Ultreia LP also filed stake reports on 2 other companies: Airsculpt Technologies, Inc. (Apr 2026), Neuronetics, Inc. (Mar 2026)
- Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026)
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/exagen